Search

Jeffrey T. Knapp

Examiner (ID: 13648)

Most Active Art Unit
3205
Art Unit(s)
3202, 3616, 3205, 1722, 1725
Total Applications
712
Issued Applications
662
Pending Applications
22
Abandoned Applications
28

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7436444 [patent_doc_number] => 20040266877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Liquid pharmaceutical compositions comprising thyroid hormones' [patent_app_type] => new [patent_app_number] => 10/802659 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2736 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266877.pdf [firstpage_image] =>[orig_patent_app_number] => 10802659 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/802659
Liquid pharmaceutical compositions comprising thyroid hormones Mar 14, 2004 Abandoned
Array ( [id] => 7297587 [patent_doc_number] => 20040214861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Compositions of a cyclooxygenase-2 selective inhibitors and 5-HT1B1D antagonists for the treatment and prevention of migraine' [patent_app_type] => new [patent_app_number] => 10/794041 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20608 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214861.pdf [firstpage_image] =>[orig_patent_app_number] => 10794041 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/794041
Compositions of a cyclooxygenase-2 selective inhibitors and 5-HT1B1D antagonists for the treatment and prevention of migraine Mar 4, 2004 Abandoned
Array ( [id] => 464460 [patent_doc_number] => 07238814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Compositions of S-nitrosothiols and methods of use' [patent_app_type] => utility [patent_app_number] => 10/781705 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17186 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238814.pdf [firstpage_image] =>[orig_patent_app_number] => 10781705 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/781705
Compositions of S-nitrosothiols and methods of use Feb 19, 2004 Issued
Array ( [id] => 7427034 [patent_doc_number] => 20040229854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Immediate release dosage form for HRT' [patent_app_type] => new [patent_app_number] => 10/781493 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4829 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229854.pdf [firstpage_image] =>[orig_patent_app_number] => 10781493 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/781493
Immediate release dosage form for HRT Feb 17, 2004 Abandoned
Array ( [id] => 7151030 [patent_doc_number] => 20040171598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Use of steroids to treat persons suffering from ocular disorders' [patent_app_type] => new [patent_app_number] => 10/771829 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2904 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171598.pdf [firstpage_image] =>[orig_patent_app_number] => 10771829 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/771829
Use of steroids to treat persons suffering from ocular disorders Feb 3, 2004 Abandoned
Array ( [id] => 7424329 [patent_doc_number] => 20040208844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Products and drug delivery vehicles' [patent_app_type] => new [patent_app_number] => 10/485023 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9757 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208844.pdf [firstpage_image] =>[orig_patent_app_number] => 10485023 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/485023
Products and drug delivery vehicles Jan 27, 2004 Abandoned
Array ( [id] => 7336883 [patent_doc_number] => 20040132688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C' [patent_app_type] => new [patent_app_number] => 10/739962 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17058 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132688.pdf [firstpage_image] =>[orig_patent_app_number] => 10739962 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/739962
Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C Dec 16, 2003 Abandoned
Array ( [id] => 7097179 [patent_doc_number] => 20050129637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Pigment dispersion for cosmetics, cosmetic compositions containing the same, and process for making such cosmetic compositions' [patent_app_type] => utility [patent_app_number] => 10/735670 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3964 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129637.pdf [firstpage_image] =>[orig_patent_app_number] => 10735670 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/735670
Pigment dispersion for cosmetics, cosmetic compositions containing the same, and process for making such cosmetic compositions Dec 15, 2003 Abandoned
Array ( [id] => 7677201 [patent_doc_number] => 20040152625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Method for improving the pharmacokinetics of an NNRTI' [patent_app_type] => new [patent_app_number] => 10/736301 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4160 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152625.pdf [firstpage_image] =>[orig_patent_app_number] => 10736301 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/736301
Method for improving the pharmacokinetics of an NNRTI Dec 14, 2003 Abandoned
Array ( [id] => 7070094 [patent_doc_number] => 20050245479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Myeloglycan' [patent_app_type] => utility [patent_app_number] => 10/726517 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 9793 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245479.pdf [firstpage_image] =>[orig_patent_app_number] => 10726517 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/726517
Myeloglycan Dec 3, 2003 Abandoned
Array ( [id] => 7326139 [patent_doc_number] => 20040138464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => '2-Oxadiazolechromone derivatives' [patent_app_type] => new [patent_app_number] => 10/725346 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14622 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138464.pdf [firstpage_image] =>[orig_patent_app_number] => 10725346 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/725346
2-oxadiazolechromone derivatives Dec 1, 2003 Issued
Array ( [id] => 7238523 [patent_doc_number] => 20040157802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Anti-microbial agents derived from methionine sulfoximine analogues' [patent_app_type] => new [patent_app_number] => 10/715679 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9967 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157802.pdf [firstpage_image] =>[orig_patent_app_number] => 10715679 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/715679
Anti-microbial agents derived from methionine sulfoximine analogues Nov 16, 2003 Abandoned
Array ( [id] => 7157118 [patent_doc_number] => 20050027116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Solid phase synthesis' [patent_app_type] => utility [patent_app_number] => 10/685331 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5208 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20050027116.pdf [firstpage_image] =>[orig_patent_app_number] => 10685331 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/685331
Solid phase synthesis Oct 13, 2003 Abandoned
Array ( [id] => 7223963 [patent_doc_number] => 20050261207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Glucose-based compounds with affinity to p-selectin' [patent_app_type] => utility [patent_app_number] => 10/530601 [patent_app_country] => US [patent_app_date] => 2003-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6486 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261207.pdf [firstpage_image] =>[orig_patent_app_number] => 10530601 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/530601
Glucose-based compounds with affinity to P-selectin Oct 12, 2003 Issued
Array ( [id] => 7281286 [patent_doc_number] => 20040063663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Acylated cyclodextrin: guest molecule inclusion complexes' [patent_app_type] => new [patent_app_number] => 10/675900 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12666 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063663.pdf [firstpage_image] =>[orig_patent_app_number] => 10675900 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/675900
Acylated cyclodextrin: guest molecule inclusion complexes Sep 29, 2003 Abandoned
Array ( [id] => 7674688 [patent_doc_number] => 20040127430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Chiral monophosphorus compounds and their transition metal complexes' [patent_app_type] => new [patent_app_number] => 10/660150 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6950 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127430.pdf [firstpage_image] =>[orig_patent_app_number] => 10660150 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/660150
Chiral monophosphorus compounds and their transition metal complexes Sep 10, 2003 Abandoned
Array ( [id] => 7306473 [patent_doc_number] => 20040116501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors' [patent_app_type] => new [patent_app_number] => 10/654365 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4857 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116501.pdf [firstpage_image] =>[orig_patent_app_number] => 10654365 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/654365
Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors Sep 2, 2003 Abandoned
Array ( [id] => 6739831 [patent_doc_number] => 20030157200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Use of oligosaccharides to stimulate beta-endorphin production' [patent_app_type] => new [patent_app_number] => 10/332136 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4107 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157200.pdf [firstpage_image] =>[orig_patent_app_number] => 10332136 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/332136
Use of oligosaccharides to stimulate beta-endorphin production Jan 5, 2003 Abandoned
Array ( [id] => 6797518 [patent_doc_number] => 20030176392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Treatment of EBV and KHSV infection and associated abnormal cellular proliferation' [patent_app_type] => new [patent_app_number] => 10/326444 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 42546 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176392.pdf [firstpage_image] =>[orig_patent_app_number] => 10326444 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/326444
Treatment of EBV and KHSV infection Dec 18, 2002 Issued
Array ( [id] => 7097172 [patent_doc_number] => 20050129630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Utilization of natural pigments from lichens, cyanobacteria, fungi and plants for sun protection' [patent_app_type] => utility [patent_app_number] => 10/488426 [patent_app_country] => US [patent_app_date] => 2002-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6111 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129630.pdf [firstpage_image] =>[orig_patent_app_number] => 10488426 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/488426
Utilization of natural pigments from lichens, cyanobacteria, fungi and plants for sun protection Sep 2, 2002 Abandoned
Menu